Page header
Blood and Marrow Transplant

Research

The Fred Hutch Blood and Marrow Transplant program at Seattle Cancer Care Alliance (SCCA) had its beginnings in the 1970s, when Nobel Prize-winner E. Donnall Thomas, MD, and his team at Fred Hutchinson Cancer Research Center first developed clinical use of transplants.

Today, the internationally renowned physician-scientists at SCCA, Fred Hutch and UW Medicine join together and continue to lead with new discoveries related to blood and marrow transplant (BMT) — which ultimately creates more treatment options for patients like you. 

When your care team designs your treatment plan, they will look for any clinical trials that might match your situation. If so, your care team will talk with you about whether you might want to join a particular study and why. This can help you make the decision that’s best for you. If you join a clinical trial, you will see the same physicians and nurses as you would for standard therapy.

How treatment works here

The safest, most effective and most widely accepted therapies for cancer become the “standard of care.” For many patients, these are the foundation of treatment. At SCCA, we provide all standard therapies for all types of cancer. 

Our physicians and researchers are always asking how we can make blood and marrow transplant better. Reduce side effects further. And tell each patient, “Good news. No signs of disease.” This is why we conduct clinical trials. Through BMT studies — which we pioneered nearly a half-century ago — we’re able to offer you therapies that are not available everywhere. A therapy that is now in trials may become the new standard tomorrow.

“Important new developments are showing the way to a further improvement in results so that many more patients with otherwise incurable diseases will have a reasonable chance of long survival and cure.”
— E. Donnall Thomas, MD, 1990 Nobel Laureate

More stories

'Just floored': Woman finally meets bone marrow donor who saved her life
In 2018, Tia Jensen was diagnosed with leukemia. She needed a bone marrow transplant, but she couldn’t be her own donor. Find out what happened after she went on a waiting list for a match.

Read More

Big gains in bone marrow transplant survival since mid-2000s
In 2010, a team at Fred Hutchinson Cancer Research Center reported a striking improvement in survival for patients who had a bone marrow transplant from the 1990s through the early 2000s. The team’s latest analysis shows that trend has continued. The overall risk of death after transplant dropped 34% between 2003-2007 and 2013-2017.

Read More